Detailed Information

Cited 84 time in webofscience Cited 94 time in scopus
Metadata Downloads

Impact of Sphingomyelin Synthase 1 Deficiency on Sphingolipid Metabolism and Atherosclerosis in Mice

Authors
Li, ZhiqiangFan, YifanLiu, JingLi, YanHuan, ChongminBui, Hai H.Kuo, Ming-ShangPark, Tae-SikCao, GuoqingJiang, Xian-Cheng
Issue Date
Jul-2012
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Keywords
sphingomyelin synthase 1; sphingomyelin; glucosylceramide synthase; glycosphingolipids; inflammation; bone marrow transplantation; atherosclerosis
Citation
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, v.32, no.7, pp.1577 - 1584
Journal Title
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume
32
Number
7
Start Page
1577
End Page
1584
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/16305
DOI
10.1161/ATVBAHA.112.251538
ISSN
1079-5642
Abstract
Objective-Sphingomyelin synthase (SMS) catalyzes the conversion of ceramide to sphingomyelin and sits at the crossroads of sphingolipid biosynthesis. SMS has 2 isoforms: SMS1 and SMS2. Although they have the same SMS activity, they are different enzymes with distinguishable subcellular localizations and cell expression patterns. It is conceivable that these differences could yield different consequences, in terms of sphingolipid metabolism and its related atherogenesis. Methods and Results-We created Sms1 gene knockout mice and found that Sms1 deficiency significantly decreased plasma, liver, and macrophage sphingomyelin (59%, 45%, and 54%, respectively), but only had a marginal effect on ceramide levels. Surprisingly, we found that Sms1 deficiency dramatically increased glucosylceramide and GM3 levels in plasma, liver, and macrophages (4- to 12-fold), whereas Sms2 deficiency had no such effect. We evaluated the total SMS activity in tissues and found that Sms1 deficiency causes 77% reduction in SMS activity in macrophages, indicating SMS1 is the major SMS in macrophages. Moreover, Sms1-deficient macrophages have a significantly higher glucosylceramide synthase activity. We also found that Sms1 deficiency significantly attenuated toll-like 4 receptor-mediated nuclear factor-kappa B and mitogen-activated protein kinase activation after lipopolysaccharide treatment. To evaluate atherogenicity, we transplanted Sms1 knockout mouse bone marrow into low-density lipoprotein receptor knockout mice (Sms1(-/-)-> Ldlr(-/-)). After 3 months on a western diet, these animals showed a significant decrease of atherosclerotic lesions in the root and the entire aorta (35% and 44%, P<0.01, respectively) and macrophage content in lesions (51%, P<0.05), compared with wild-type -> Ldlr(-/-) mice. Conclusion-Sms1 deficiency decreases sphingomyelin, but dramatically increases the levels of glycosphingolipids. Atherosclerosis in Sms1(-/-)-> Ldlr(-/-) mice is significantly decreased. (Arterioscler Thromb Vasc Biol. 2012;32:1577-1584.)
Files in This Item
There are no files associated with this item.
Appears in
Collections
바이오나노대학 > 생명과학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, Tae Sik photo

Park, Tae Sik
BioNano Technology (Department of Life Sciences)
Read more

Altmetrics

Total Views & Downloads

BROWSE